VHL and nonpapillary renal cell carcinoma: Our results provide the basis for an integrated pathological and molecular genetic classification of ccRCC, which takes into account disease-specific panels of genes, such as VHL, BAP1, PBRM1 and SETD2, thereby paving the way for subtype-specific treatments that exploit genetic abnormalities.